Familial Hypercholesterolemia Clinical Trials

A listing of Familial Hypercholesterolemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Florida

Clinical Research of South Florida
Coral Gables Florida 33134

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Evolocumab (AMG 145) on LDL-C in Subjects With Type 2 Diabetes Mellitus and Hypercholesterolemia/Mixed Dyslipidemia Protocol Number (AMG 145/Evolocumab) 20130287

View More ▼

Clearwater Florida

A Phase 3 clinical study for patients with Hypercholesterolemia or Atherosclerotic Cardiovascular Disease

Jacksonville Florida 32216

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Indiana

Indianapolis Indiana 46260

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

New York

The Rogosin Institute
New York New York 10021

CASCADE FH Registry: Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia

View More ▼

New York New York 10029

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Ohio

UPDATED

Cincinnati Ohio 45227

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Cincinnati Ohio 45227

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Cincinnati Ohio 45246

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Tennessee

Greeneville Tennessee 37745

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Texas

Amarillo Texas 79106

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Georgetown Texas

A Phase 3 clinical study for patients with Hypercholesterolemia or Atherosclerotic Cardiovascular Disease

Virginia

Richmond Virginia 23294

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Wisconsin

Kenosha Wisconsin

A Phase 3 clinical study for patients with Hypercholesterolemia, Atherosclerotic Cardiovascular Disease or Statin Adverse Reaction

Australia

UPDATED

Camperdown New South Wales 2050

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Austria

UPDATED

Feldkirch 6800

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

UPDATED

Wien 1090

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Belgium

UPDATED

Brussels 1200

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Canada

Brampton Ontario L6Z 4N5

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

UPDATED

Chicoutimi Quebec G7H 7K9

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

UPDATED

Chicoutimi Quebec G7H 5H6

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Chicoutimi Quebec G7H 7K9

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

London Ontario 0015199315271

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

View More ▼

Montreal Quebec H3A1A1

A clinical trial seeking patients for a research study for the treatment of Familial Hypercholesterolemia or Lipid Disorder

Montreal Quebec H1T 3Y7

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Montreal Quebec H2W 1R7

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

UPDATED

Quebec G1V 4W2

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Quebec G1V 4W2

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Quebec G1V 4G5

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Sherbrooke Quebec J1H 5N4

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Toronto Ontario M5C 2T2

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Toronto Ontario M9L 3A2

Patients are needed to participate in a clinical research study evaluating IONIS ANGPTL3-LRx and Placebo (0.9%NaCl, water, riboflavin) for the treatment of Hypertriglyceridemia or Familial Hypercholesterolemia

Winnipeg Manitoba R2H 2A6

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Czechia

UPDATED

Svitavy 568 25

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

France

Paris 75013

A clinical trial seeking patients for a research study for the treatment of Familial Hypercholesterolemia - Heterozygous

Germany

Berlin 12203

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Essen 45355

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Frankfurt 60590

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Heidelberg 69120

Patients are needed to participate in a clinical research study evaluating Inclisiran and Evolocumab for the treatment of Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes or Familial Hypercholesterolemia

Greece

UPDATED

Athens 17674

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

UPDATED

Thessaloniki 54642

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Hungary

UPDATED

Budapest 1094

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Italy

UPDATED

Palermo 90127

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

UPDATED

Pisa 56124

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

UPDATED

Roma 00161

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

UPDATED

Torino 10126

Patients are needed to participate in a clinical research study evaluating evolocumab (AMG 145) for the treatment of Familial Hypercholesterolemia

Japan

Ageo city Saitama prefecture 362-8588

A Phase 4 clinical study for patients with Hypercholesterolemia or Familial Hypercholesterolemia

Akita city Akita prefecture 010-1423

A Phase 4 clinical study for patients with Hypercholesterolemia or Familial Hypercholesterolemia

Asahi city Chiba prefecture 289-2511

A Phase 4 clinical study for patients with Hypercholesterolemia or Familial Hypercholesterolemia

Chiba City Chiba prefecture 260-8677

A Phase 4 clinical study for patients with Hypercholesterolemia or Familial Hypercholesterolemia